Last $4.22 USD
Change Today -0.03 / -0.71%
Volume 3.0M
ARNA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 4:00 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

arena pharmaceuticals inc (ARNA) Key Developments

Arena Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Arena Pharmaceuticals, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenues totaled $12,801,000 against $68,927,000 a year ago. Net income was $7,480,000 or $0.03 per diluted share against $40,100,000 or $0.18 per diluted share a year ago. For the six months, the company reported total revenues of $19,615,000 against $71,300,000 a year ago. Net loss was $17,775,000 or $0.08 per diluted share against net income of $21,224,000 or $0.09 per diluted share a year ago.

Arena Pharmaceuticals, Inc. to Report Q2, 2014 Results on Aug 01, 2014

Arena Pharmaceuticals, Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Aug 01, 2014

Arena Pharmaceuticals, Inc., Q2 2014 Earnings Call, Aug 01, 2014

Arena Pharmaceuticals, Inc., Q2 2014 Earnings Call, Aug 01, 2014

Arena Pharmaceuticals, Inc. Initiates Phase 1B Clinical Trial of APD334 for Autoimmune Diseases

Arena Pharmaceuticals, Inc. announced the initiation of dosing in an investigational Phase 1b clinical trial of APD334, a novel, oral drug candidate that targets the sphingosine 1-phosphate subtype 1 (S1P(1)) receptor, to evaluate the compound for the treatment of a number of autoimmune diseases. This randomized, double-blind and placebo-controlled Phase 1b trial will evaluate the safety, tolerability and pharmacokinetics of multiple-ascending doses of APD334 in up to 96 healthy adult volunteers.

Arena Pharmaceuticals, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-03-2014 11:30 AM

Arena Pharmaceuticals, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-03-2014 11:30 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Jack Lief, Co-Founder, Chairman, Chief Executive Officer and President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARNA:US $4.22 USD -0.03

ARNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ARNA.
View Industry Companies
 

Industry Analysis

ARNA

Industry Average

Valuation ARNA Industry Range
No financial data is available for ARNA.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARENA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.